StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a report issued on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Stock Performance
Onconova Therapeutics has a 1 year low of $0.55 and a 1 year high of $1.45. The company has a market cap of $20.90 million, a price-to-earnings ratio of -1.09 and a beta of 1.38. The firm’s fifty day moving average price is $0.85 and its two-hundred day moving average price is $0.74.
About Onconova Therapeutics
Featured Stories
- Five stocks we like better than Onconova Therapeutics
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MarketBeat Week in Review – 4/29 – 5/3
- Canadian Penny Stocks: Can They Make You Rich?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- 3 REITs to Buy and Hold for the Long Term
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.